| Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal … R Hammerstingl, A Huppertz, J Breuer, T Balzer, A Blakeborough, ... European radiology 18, 457-467, 2008 | 464 | 2008 |
| Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial S Gauthier, HH Feldman, LS Schneider, GK Wilcock, GB Frisoni, ... The Lancet 388 (10062), 2873-2884, 2016 | 409 | 2016 |
| Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. P Reimer, EJ Rummeny, K Shamsi, T Balzer, HE Daldrup, B Tombach, ... Radiology 199 (1), 177-183, 1996 | 370 | 1996 |
| Potential of low dose leuco-methylthioninium bis (hydromethanesulphonate)(LMTM) monotherapy for treatment of mild Alzheimer’s disease: Cohort analysis as modified primary … GK Wilcock, S Gauthier, GB Frisoni, J Jia, JH Hardlund, HJ Moebius, ... Journal of Alzheimer's disease 61 (1), 435-457, 2018 | 198 | 2018 |
| Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US TJ Vogl, W Schwarz, S Blume, M Pietsch, K Shamsi, M Franz, H Lobeck, ... European radiology 13, 262-272, 2003 | 181 | 2003 |
| Focal nodular hyperplasia of the liver: radiologic findings K Shamsi, A De Schepper, H Degryse, F Deckers Abdominal imaging 18, 32-38, 1993 | 155 | 1993 |
| MR Angiography of Aortoiliac Occlusive Disease: A Phase III Study of the Safety and Effectiveness of the Blood-Pool Contrast Agent MS-3251 M Goyen, M Edelman, P Perreault, E O'Riordan, H Bertoni, J Taylor, ... Radiology 236 (3), 825-833, 2005 | 135 | 2005 |
| Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography—multicenter … JH Rapp, SD Wolff, SF Quinn, JA Soto, SG Meranze, S Muluk, J Blebea, ... Radiology 236 (1), 71-78, 2005 | 123 | 2005 |
| MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial P Perreault, MA Edelman, RA Baum, EK Yucel, RM Weisskoff, K Shamsi, ... Radiology 229 (3), 811-820, 2003 | 95 | 2003 |
| Coronary arteries: contrast-enhanced MR imaging with SH L 643A—experience in 12 volunteers CU Herborn, J Barkhausen, I Paetsch, P Hunold, M Mahler, K Shamsi, ... Radiology 229 (1), 217-223, 2003 | 93 | 2003 |
| T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic … P Reimer, M Müller, C Marx, D Wiedermann, R Muller, EJ Rummeny, ... Radiology 209 (3), 831-836, 1998 | 92 | 1998 |
| Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial SS Raman, C Leary, DA Bluemke, M Amendola, D Sahani, JD McTavish, ... Journal of computer assisted tomography 34 (2), 163-172, 2010 | 86 | 2010 |
| Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging. K Shamsi, T Balzer, S Saini, PR Ros, RC Nelson, EC Carter, S Tollerfield, ... Radiology 206 (2), 365-371, 1998 | 81 | 1998 |
| Vasovist-enhanced MR angiography M Goyen, K Shamsi, SO Schoenberg European Radiology Supplements 16, B9-B14, 2006 | 71 | 2006 |
| Dynamic MR imaging of liver metastases with Gd-EOB-DTPA W Stern, F Schick, AF Kopp, P Reimer, K Shamsi, CD Claussen, ... Acta Radiologica 41 (3), 255-262, 2000 | 69 | 2000 |
| A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: phase II and phase III clinical trials data K Shamsi, EK Yucel, P Chamberlin Investigative radiology 41 (11), 822-830, 2006 | 66 | 2006 |
| SPIO‐enhanced 2D‐TOF MR angiography of the portal venous system: results of an intraindividual comparison P Reimer, C Marx, EJ Rummeny, M Müller, M Lentschig, T Balzer, ... Journal of Magnetic Resonance Imaging 7 (6), 945-949, 1997 | 64 | 1997 |
| MR coronary angiography with SH L 643 A: initial experience in patients with coronary artery disease CU Herborn, M Schmidt, O Bruder, E Nagel, K Shamsi, J Barkhausen Radiology 233 (2), 567-573, 2004 | 45 | 2004 |
| Eovist Injection and Resovist Injection: two new liver-specific contrast agents for MRI. J Mintorovitch, K Shamsi Oncology (Williston Park, NY) 14 (6 Suppl 3), 37-40, 2000 | 45 | 2000 |
| Detection of focal liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA. SA Schmitz, JH Häberle, T Balzer, K Shamsi, J Boese-Landgraf, KJ Wolf Radiology 202 (2), 399-405, 1997 | 32 | 1997 |
